Back
Akero Therapeutics Stock Predictions

Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
AKRO
Akero Therapeutics
Last Price:
$51.82
Seasonality Move:
-15.52%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Space Move Could Send This Pre-IPO Stock Soaring
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Akero Therapeutics Stock Forecast
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 39.7% based on the past 5 years of stock performance.
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Akero Therapeutics Stock Undervalued?The current Akero Therapeutics [AKRO] share price is $50.58. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Akero Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 39.7% based on the past 5 years of stock performance.
Akero Therapeutics Stock Rating
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics overpriced?
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Akero Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com
52-Week Data
52-Week High:
58.40
52-Week Low:
17.86
Prediction Charts
Market Cap:
3.5B
Price in USD:
50.58
Volume:
810.6K
Beta:
-0.15
Technical Analysis
SMA50:
36.45
SMA100:
33.47
SMA200:
28.76
52-Wk Change:
133.95%
Stock Predictions
-
Is Akero Therapeutics stock public?Yes, Akero Therapeutics is a publicly traded company.
-
What is the Akero Therapeutics stock quote today?The Akero Therapeutics stock price is 50.58 USD today.
-
How to buy Akero Therapeutics stock online?You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-31 | 54.82 | 54.08 | 55.88 | 52.89 |
Feb-3 | 53.77 | 53.85 | 54.69 | 52.63 |
Feb-4 | 53.60 | 56.41 | 57.25 | 53.60 |
Feb-5 | 56.87 | 57.56 | 57.66 | 55.60 |
Feb-6 | 57.12 | 54.95 | 57.78 | 54.32 |
Feb-7 | 54.81 | 54.21 | 55.32 | 53.88 |
Feb-10 | 55.81 | 51.15 | 55.81 | 51.06 |
Feb-11 | 50.51 | 49.95 | 51.13 | 48.90 |
Feb-12 | 49.21 | 49.44 | 50.70 | 48.84 |
Feb-13 | 49.48 | 49.23 | 49.92 | 48.57 |
Feb-14 | 49.24 | 50.52 | 51.40 | 49.24 |
Feb-18 | 51.39 | 49.44 | 51.39 | 49.35 |
Feb-19 | 49.46 | 50.67 | 50.76 | 48.70 |
Feb-20 | 50.82 | 50.58 | 51.39 | 50.12 |
Akero Therapeutics Earnings
Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Akero Therapeutics Forecast Revenue Growth
Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.